In vitro evaluation of three different biomaterials as scaffolds for canine mesenchymal stem cells

Acta Cirurgica Brasileira

Volumn 28, Issue 5, 2013, Pages 353-360

  Pereira Júnior, Oduvaldo Câmara Marques ^a   Rahal, Sheila Canevese ^a   Lima Neto, João Ferreira ^a   Landim Alvarenga, Fernanda da Cruz ^a   Monteiro, Frederico Ozanan Barros ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSIDADE FEDERAL RURAL DA AMAZÔNIA   (Brazil)

Author keywords

Bone matrix; Castor oil; Hydroxyapatites; Polyurethanes; Stem cells

Indexed keywords

ALIZARIN RED S; CASTOR OIL; HYDROXYAPATITE; POLYURETHAN; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR OSTERIX;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MATRIX; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; DOG; FIBROBLAST; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PHASE CONTRAST MICROSCOPY; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; BONE MATRIX; BONE REGENERATION; BONE SUBSTITUTES; CASTOR OIL; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOGS; DURAPATITE; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; POLYURETHANES; SURFACE PROPERTIES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84878302642     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502013000500006     Document Type: Article

References (39)

1. Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA. The new stem cell biology: something for everyone. Mol Pathol. 2003;56:86-96.
2. Oreffo ROC, Cooper C, Mason C, Clements M. Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 2005;1:169-78.
3. Alison MR, Islam S. Attributes of adult stem cells. J Pathol. 2009;217(2):144-60.
4. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001;226(6):507-20.
5. Caplan AI. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005;11(7/8):1198-211.
6. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by mesenchymal stem cells. A potential therapeutic strategy for type 1 diabetes. Diabetes. 2008;57:1759-67.
7. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nature. 2008;8:726-36.
8. Fibbe WE. Mesenchymal stem cells. A potential source for skeletal repair. Ann Rheum Dis. 2002;61(Suppl 2):ii29-31.
9. Kassem M. Mesenchymal stem cells: biological characteristics and potential clinical applications. Cloning Stem Cells. 2004;6(4):369-74.
10. Friedenstein AJ, Petrakova KV, Kurolesova AL. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-47.
11. Alhadlaq A, Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 2004;13:436-48.
12. Koc ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant. 2001;27:235-9.
13. Logeart-Avramoglou D, Anagnostou F, Bizios R. Engineering bone: challenges and obstacles. J Cell Mol Med. 2005;9:72-84.
14. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud TS. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am. 1994;76:827-38.
15. Bruder SR, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res. 1998;(355 Suppl):S247-56.
16. Itho T, Mochizuki M, Nishimura R, Matsunaga S, Kadosawa T, Kokubo S, Yokota S, Sasaki N. Repair of ulnar segmental defect by recombinant human bone morphogenetic protein-2 in dogs. J Vet Med Sci. 1998;60:451-8.
17. Pereira-Júnior OCM, Rahal SC, Iamaguti P, Felisbino SL, Pavan PT, Vulcano LC. Comparison between polyurethanes containing castor oil (soft segment) and cancellous bone autograft in the treatment of segmental bone defect induced in rabbits. J Biomat Appl. 2007;21:283-97.
18. Goldberg V, Stevenson S. Natural history of autografts and allografts. Clin Orthop. 1987;225:7-16.
19. Olivier V, Faucheux N, Hardouin P. Biomaterial challenges and approaches to stem cell use in bone reconstructive surgery. Drug Discov Today. 2004;9(18):803-11.
20. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: an update. Injury. 2005;36:S20-7.
21. Perry CR. Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop Relat Res. 1999;360:71-86.
22. Khan SN, Tomin E, Lane JM. Clinical applications of bone graft substitutes. Orthop Clin North Am. 2000;31(3):389-98.
23. Ohgushi H, Caplan AI. Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res. 1999;48:913-27.
24. Warren SM, Nacamuli RK, Song HM, Longaker MT. Tissueengineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg. 2004;15(1):34-7.
25. Vats A, Tolley NS, Polak JM, Buttery LDK. Stem cells: sources and applications. Clin Otolaryngol. 2002;27:227-32.
26. Burg KJL, Porter S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials.2000;21:2347-59.
27. Silva TSN, Primo BT, Silva Júnior AN, Machado DC, Viezzer C, Santos LA. Use of calcium phosphate cement scaffolds for bone tissue engineering: in vitro study. Acta Cir Bras. 2011;26:1-11.
28. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. Mesenchymal stem cells. Arch Med Res. 2003;34:565-71.
29. Kadiyala S, Jaiswal N, Bruder SP. Culture-expanded, bone marrow derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Eng. 1997;3(2):173-85.
30. Bioosteo. Bioosteo. (2010). Available from: . [cited 2010 Jul 21].
31. Ignácio H. Avaliação da poliuretana da mamona nas formas compacta e porosa no preenchimento da falha óssea. Estudo experimental em cães [thesis]. School of Medicine, Sao Paulo University, Brazil; 1999.
32. Beloti MM, Hiraki KR, Barros VM, Rosa AL. Effect of the chemical composition of Ricinus communis polyurethane on rat bone marrow cell attachment, proliferation, and differentiation. J Biomed Mater Res. 2003;64(1):171-6.
33. Lu JX, Flautre B, Anselme K, Hardouin P, Gallur A, Descamps M, Thierry B. Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. J Mater Sci Mater Med. 1999;10(2):111-20.
34. Gebhart M, Lane J. A radiographycal and biomechanical study of demineralized bone matrix implanted into a bone defect of rat femurs with and without bone marrow. Acta Orthop Belg. 1991;57(2):130-43.
35. De Long WG, Einhorn TA, Koval K, Mckee M, Smith W, Sanders R, Watson T. Current concepts review: bone grafts and bone graft substitutes in orthopedic trauma surgery. J Bone Joint Surg Am. 2007;89:649-58.
36. Kasten P, Luginbuhl R, Van Griensven M, Barkhausen T, Krettek C, Bohner M, Bosch U. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, b-tricalcium phosphate and demineralized bone matrix. Biomaterials. 2003;24:2593-603.
37. Legeros RG. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res. 2002;395:81-98.
38. Niemeyer P, Krause U, Fellenberg J, Kasten P, Seckinger A, Ho AD, Simank H. Evaluation of mineralized collagen and tricalcium phosphate as scaffolds for tissue engineering of bone using human mesenchymal stem cells. Cells Tissues Organs. 2004;177:68-78.
39. Kotobuki N, Ioku K, Kawagoe D, Fujimori H, Goto S, Ohgushi H. Observation of osteogenic differentiation cascade of living mesenchymal stem cells on transparent hydroxyapatite ceramics. Biomaterials. 2005;26(7):779-85.